News & Perspective

Apr 11, 2013

Apr 11, 2013

China reports five more H7N9 cases, one fatal

(CIDRAP News) – New reports of H7N9 avian influenza cases from eastern China continued at a steady pace today, with five more infections and one death confirmed by officials in Shanghai and Jiangsu province.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 01, 2007

Nov 01, 2007

THE PANDEMIC VACCINE PUZZLE Part 6: Looking to novel vaccine technologies

Editor's note: This is the sixth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.

Oct 29, 2007

Oct 29, 2007

THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges

Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Apr 12, 2007

Apr 12, 2007

Insect-cell-based flu vaccine looks good in clinical trial

(CIDRAP News) – An influenza vaccine grown in insect cells instead of chicken eggs proved safe and yielded a good immune response in a trial in healthy adults, possibly signaling a significant advance in flu vaccine production technology, according to a report published this week in the Journal of the American Medical Association (JAMA).

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Mar 31, 2006

Mar 31, 2006

Indonesia confirms H5N1 case; more suspected

(CIDRAP News) – Indonesia has confirmed a case of H5N1 avian influenza in a 1-year-old girl who died last week, and the illness is suspected in another Indonesian and in a teenager in Azerbaijan, according to news services.

Feb 13, 2006

Feb 13, 2006

More countries facing H5N1 flu in birds

(CIDRAP News) – The H5N1 avian flu virus is continuing its relentless spread from bird to bird, with individual deaths in some countries marking new territory for the virus and massive die-offs and culling showing how quickly it can become entrenched.

The pathogen has been reported in wild birds in five new countries—Azerbaijan, Nigeria, Greece, Italy, and Bulgaria—in the past week. In addition, an H5 virus has been reported in Slovenia.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»